A national, multicenter, prospective, single-arm registry PASS of pulmonary hypertension patients treated with Riociguat (Adempas®) in China (MK-4836-001) (EXPERT China)

First published 12/02/2021

Last updated 23/04/2024

EU PAS number:

EUPAS39007

Study

Finalised

Documents

Study protocol

Initial protocol

MK-4836-001-01-Prot_Final Redaction

English (377.18 KB - PDF) View document

Study results

MK-4836-001-final-report-MAR-2021-EXPERT-CHINA_Final Redaction

English (688.45 KB - PDF) View document

Study report

Other information

Secondary tabs